Skip to main content
. Author manuscript; available in PMC: 2016 Jul 15.
Published in final edited form as: Bioconjug Chem. 2015 Apr 6;26(7):1224–1236. doi: 10.1021/acs.bioconjchem.5b00070

Figure 9.

Figure 9

In vitro characterization of PLP-modified fibrin. (A) PLPs have multivalent display of fibrin-binding nanobodies. (B) PLP increases the density of the fibrin matrix in comparison to non-binding microgel controls (S11-ULC). (C) PLP integration in clots results in contraction 48 hours after fibrin polymerization [reproduced with permission from 91].